Early identification of cancer survivors at risk of heart failure (HF) is essential to enable preventive intervention. Existing tools such as the HFA-ICOS (Heart Failure Association and the International Cardio-Oncology Society) risk score incorporate clinical examination, cardiac biomarkers and imaging, limiting...
C. Soh, M. Gynnild, H. Dalen et al.· European Heart Journal· 0 citations
Early identification of stage B heart failure (SBHF) in individuals with type 2 diabetes mellitus (T2DM) may allow timely initiation of cardioprotective therapies and help prevent progression to symptomatic heart failure. However, cardiovascular risk in T2DM is heterogeneous, and a selection process for echocardi...
A. Węgrzyn-Witek, C. Soh, W. Kosmala et al.· European Heart Journal· 0 citations
Artificial intelligence-enhanced electrocardiogram shows moderate discrimination for subclinical HF, with significant improvement in predictive accuracy when combined with CHERISH risk score among cancer survivors, and compares it with clinically-derived and electronic medical record-based HF risk scores.
J. Chen, De A. B. Sa, J. Wong et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.